Analysis reveals predictive factors for clinical outcomes in differentiated thyroid cancer with incomplete response after radioiodine therapy, suggesting potential for improved patient management.
Purpose The aim of our study was to investigate the clinical outcomes and predictive factors in patients with biochemical incomplete response (BIR) after initial radioiodine therapy (RAI).
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: